-
公开(公告)号:US20240218370A1
公开(公告)日:2024-07-04
申请号:US18191611
申请日:2023-03-28
Applicant: OSPEDALE SAN RAFFAELE S.R.L. , Fondazione Telethon
Inventor: Luigi Naldini , Brian Brown
IPC: C12N15/113 , C12N15/63 , C12N15/86
CPC classification number: C12N15/1137 , C12N15/635 , C12N15/86 , A61K48/00
Abstract: A gene vector comprising a miRNA sequence target.
-
公开(公告)号:US20220273712A1
公开(公告)日:2022-09-01
申请号:US17615766
申请日:2020-06-05
Applicant: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY , OSPEDALE SAN RAFFAELE S.R.L. , FONDAZIONE TELETHON
Inventor: Rosa Bacchetta , Maria Grazia Roncarolo , Yohei Sato , Luigi Naldini , Laura Passerini
IPC: A61K35/17 , C12N5/0783
Abstract: Engineered Treg-like cells, CD4LVFOXP3 T cells, and their use in cellular therapy to promote immune tolerance are disclosed. In particular, CD4LVFOXP3 T cells are produced by transduction of CD4+ T cells with a lentiviral vector expressing FOXP3 under the control of a constitutive promoter. Transduced cells express FOXP3 at high and persistent levels and acquire immune suppressive characteristics resembling naturally occurring Treg cells.
-
公开(公告)号:US20200078408A1
公开(公告)日:2020-03-12
申请号:US16604484
申请日:2018-04-20
Applicant: Ospedale San Raffaele S.r.l. , Fondazione Telethon
Inventor: Luigi Naldini , Giulia Escobar , Bernhard Rudolf Gentner , Adele Mucci
IPC: A61K35/28 , C12N5/0789 , C12N5/0786 , A61K35/15 , A61K38/21 , A61K35/17 , A61K39/395 , A61P35/00 , A61P35/02 , A61K31/405 , C07K16/28 , C12N15/86 , C12N7/00 , A61K48/00
Abstract: A hematopoietic stem cell (HSC), a hematopoietic progenitor cell (HPC) a myeloid/monocyte-committed progenitor cell, a macrophage or a monocyte comprising a vector wherein the vector comprises at least one mir-130a and/or mir-126 target sequence operably linked to a nucleotide sequence encoding interferon-alpha (IFNα) for use in treating or preventing a cancer in a patient, wherein the HSC, the HPC, the myeloid/monocyte-committed progenitor cell, the macrophage or the monocyte is used in combination with an immune checkpoint inhibitor and/or a tumor associated antigen (TAA)-specific T-cell.
-
公开(公告)号:US20190032049A1
公开(公告)日:2019-01-31
申请号:US15521294
申请日:2015-10-23
Applicant: Ospedale San Raffaele S.R.L. , Fondazione Telethon
Inventor: Luigi Naldini , Angelo Leone Lombardo , Angelo Amabile , Alessandro Migliara
IPC: C12N15/113 , C07K14/47 , C12N9/10 , C12N9/22
Abstract: A product comprising two or more artificial transcription repressors (ATRs), or polynucleotides encoding therefor, selected from groups (a), (b), (c) or (d): (a) an ATR comprising a DNA-binding domain operably linked to a KRAB domain or homologue thereof; (b) an ATR comprising a DNA-binding domain operably linked to a DNMT3A, DNMT3B or DNMT1 domain or homologue thereof; (c) an ATR comprising a DNA-binding domain operably linked to a DNMT3L domain or homologue thereof; and (d) an ATR comprising a DNA-binding domain operably linked to a SETDB1 domain or homologue thereof, wherein at least two of the ATRs are selected from different groups (a), (b), (c) or (d).
-
公开(公告)号:US09951328B2
公开(公告)日:2018-04-24
申请号:US15693112
申请日:2017-08-31
Applicant: Fondazione Telethon , Ospedale San Raffaele S.r.l.
Inventor: Alessandra Biffi , Bernhard Rudolf Gentner , Luigi Naldini
IPC: C12N15/63 , C12N15/113 , C12N15/86 , C12N15/11 , A61K48/00
CPC classification number: C12N15/111 , A61K48/00 , C12N2310/141 , C12N2310/51 , C12N2320/32 , C12N2330/51 , C12N2799/027
Abstract: A gene vector for use in gene therapy comprising at least one miRNA sequence target operably linked to a nucleotide sequence having a corresponding miRNA in a hematopoietic progenitor cell (HSPC) or hematopoietic stem cell (HSC) which prevents or reduces expression of the nucleotide sequence in a HSPC or HSC but not in a differentiated cell.
-
公开(公告)号:US12152240B2
公开(公告)日:2024-11-26
申请号:US15521294
申请日:2015-10-23
Applicant: Ospedale San Raffaele S.R.L. , Fondazione Telethon
Inventor: Luigi Naldini , Angelo Leone Lombardo , Angelo Amabile , Alessandro Migliara
IPC: C12N15/113 , A61K35/12 , A61K38/00 , A61K38/17 , A61K38/45 , A61K48/00 , C07K14/47 , C12N9/10 , C12N9/22
Abstract: A product comprising two or more artificial transcription repressors (ATRs), or polynucleotides encoding therefor, selected from groups (a), (b), (c) or (d): (a) an ATR comprising a DNA-binding domain operably linked to a KRAB domain or homologue thereof; (b) an ATR comprising a DNA-binding domain operably linked to a DNMT3A, DNMT3B or DNMT1 domain or homologue thereof; (c) an ATR comprising a DNA-binding domain operably linked to a DNMT3L domain or homologue thereof; and (d) an ATR comprising a DNA-binding domain operably linked to a SETDB1 domain or homologue thereof, wherein at least two of the ATRs are selected from different groups (a), (b), (c) or (d).
-
公开(公告)号:US11753643B2
公开(公告)日:2023-09-12
申请号:US16004394
申请日:2018-06-10
Applicant: OSPEDALE SAN RAFFAELE S.R.L. , Fondazione Telethon
Inventor: Luigi Naldini , Brian Brown
IPC: C12N15/113 , C12N15/63 , C12N15/86 , A61K48/00
CPC classification number: C12N15/1137 , C12N15/635 , C12N15/86 , A61K48/00 , C12N2310/141 , C12N2740/15043 , C12N2740/15045 , C12N2760/20222 , C12N2810/6081
Abstract: A gene vector comprising a miRNA sequence target.
-
公开(公告)号:US20230174622A1
公开(公告)日:2023-06-08
申请号:US17998447
申请日:2021-05-14
Applicant: Ospedale San Raffaele S.R.L. , Fondazione Telethon
Inventor: Luigi Naldini , Pietro Genovese , Valentina Vavassori
CPC classification number: C07K14/71 , C12N15/86 , C07K16/2863 , A61P37/06 , C07K2319/03
Abstract: A polynucleotide comprising a nucleotide sequence encoding an epidermal growth factor receptor (EGFR) extracellular epitope operably linked to: (a) a NGFR or GMS SFR alpha signal peptide; (b) a EGFR or NGFR transmembrane domain; and/or (c) a NGFR or EGFR cytosplasmic tail.
-
公开(公告)号:US20200338131A1
公开(公告)日:2020-10-29
申请号:US16827708
申请日:2020-03-24
Applicant: Ospedale San Raffaele S.R.L. , Fondazione Telethon
Inventor: Luigi Naldini , Bernhard Rudolf Gentner , Erika Zonari , Francesco Boccalatte
IPC: A61K35/28 , C12N5/0789 , C12N15/86 , A61K48/00
Abstract: A method of preparing a therapeutic cell population for clinical use from a starting population of cells comprising haematopoietic stem cells, said method comprising separating a population of cells that substantially do not express CD38 but which express CD34 from the starting population of cells, and transducing the separated cell population with a vector to obtain the therapeutic cell population.
-
公开(公告)号:US20190032059A1
公开(公告)日:2019-01-31
申请号:US16004394
申请日:2018-06-10
Applicant: OSPEDALE SAN RAFFAELE S.R.L. , Fondazione Telethon
Inventor: Luigi Naldini , Brian Brown
IPC: C12N15/113 , C12N15/63 , C12N15/86
Abstract: A gene vector comprising a miRNA sequence target.
-
-
-
-
-
-
-
-
-